FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 151 through 173 of 173

PHARMACEUTICAL PREPARATIONS - SIC # 2834

Ticker Exchange Company Financial Reports SIC #
SLGL Nasdaq Sol-Gel Technologies Ltd. 2834
SMDPY Over the counter Sumitomo Pharma Co., Ltd. 2834
SNDX Nasdaq Syndax Pharmaceuticals, Inc. 2834
SNY Nasdaq Sanofi 2834
SNYR Nasdaq Synergy CHC Corp. 2834
SPRB Nasdaq Spruce Biosciences, Inc. 2834
SRZN Nasdaq Surrozen, Inc. 2834
SUPN Nasdaq Supernus Pharmaceuticals, Inc. 2834
SVRA Nasdaq Savara Inc. 2834
SXTP Nasdaq 60 Degrees Pharmaceuticals, Inc. 2834
TARA Nasdaq Protara Therapeutics, Inc. 2834
TARS Nasdaq Tarsus Pharmaceuticals, Inc. 2834
TCRT Nasdaq Alaunos Therapeutics, Inc. 2834
TOVX NYSE American Theriva Biologics, Inc. 2834
UPB Nasdaq Upstream Bio, Inc. 2834
VFF Nasdaq Village Farms International, Inc. 2834
VIR Nasdaq Vir Biotechnology, Inc. 2834
VYGR Nasdaq Voyager Therapeutics, Inc. 2834
VYNE Nasdaq VYNE Therapeutics Inc. 2834
XLO Nasdaq Xilio Therapeutics, Inc. 2834
XRTX Nasdaq XORTX Therapeutics Inc. 2834
YCBD NYSE American cbdMD, Inc. 2834
ZVRA Nasdaq Zevra Therapeutics, Inc. 2834
Results 150 through 173 of 173